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ABSTRACT For many applications, antibodies need to be engineered toward maximum afﬁnity. Strategies are in demand to
especially optimize this process toward slower dissociation rates, which correlate with the (un)binding forces. Using single-
molecule force spectroscopy, we have characterized three variants of a recombinant antibody single-chain Fv fragment. These
variants were taken from different steps of an afﬁnity maturation process. Therefore, they are closely related and differ from
each other by a few mutations only. The dissociation rates determined with the atomic force microscope differ by one order of
magnitude and agree well with the values obtained from surface plasmon resonance measurements. However, the effective
potential width of the binding complexes, which was derived from the dynamic force spectroscopy measurements, was found to
be the same for the different mutants. The large potential width of 0.9 nm indicates that both the binding pocket and the peptide
deform signiﬁcantly during the unbinding process.
INTRODUCTION
In recent years, recombinant antibodies have become increas-
ingly important as therapeutic agents (1–4), for proteomics
applications, and for diagnostic assays (5). In addition, they
might prove useful as building blocks for the self-assembly
of nanostructures. Antibodies with high afﬁnities are needed
in most of the cases, and the application sets the requirements.
Several different approaches have been developed for the
in vitro afﬁnity maturation of recombinant antibody frag-
ments such as single-chain Fv (scFv) or Fab fragments (1–4,
6–11). If a number of clones have been selected, they need to
be characterized according to their afﬁnity improvement.
Often, the determination of the equilibrium dissociation con-
stant KD yields sufﬁcient information, and a ranking of mu-
tants is possible. However, in some cases it is necessary
to measure the kinetic rate constants of both the binding and
unbinding processes as a way to describe both equilibrium
and kinetic behavior in an application. This characterization
is of particular importance if the afﬁnity improvement needs
to be correlated with the structure of the mutants and the
position and type of the acquired mutation(s), e.g., during an
afﬁnity maturation process and its structural interpretation.
Several different methods exist for the determination of
the equilibrium dissociation constant. It can be measured,
e.g., with ELISA (enzyme-linked immunosorbent assay)
(12), surface plasmon resonance (SPR) (13), ﬂuorescence
titration (14), and ﬂuorescence-activated cell sorting (9). The
quantitative measurement of the kinetic constants can be
more difﬁcult. Usually, SPR is used for this purpose. To ob-
tain exact values, one has to take care of possible rebinding
effects on the surface during the dissociation phase, which
can slow down the apparent dissociation rate, koff, artiﬁ-
cially. In addition, in the case of slow dissociation rates (koff,
105 s1), an accurate determination of koff is difﬁcult due to
the small amount of analyte dissociating. The signal change
can then approach the rate of drift of the SPR instrument (15).
Single-molecule force spectroscopy is an alternative method
to obtain information about the unbinding process of receptor-
ligand interactions. This measurement method has been used
for a broad range of different biological systems, including
antibody-antigen interactions (14,16–21). Force spectros-
copy makes use of the fact that koff is increased if an external
force is applied. Measuring the rupture forces of a receptor-
ligand interaction for different loading rates (dynamic force
spectroscopy) allows extrapolation to the dissociation rate
at zero force, which represents the natural koff. Furthermore,
force spectroscopy yields additional information about the
width of the potential Dx (see below). This information
might be useful for interpreting the inﬂuence of different
mutations on unbinding kinetics. Mutations could lead to
changes in the geometry of the binding site or to other con-
formational rearrangements of the molecule, resulting in an
altered unbinding pathway that can be detected as a change in
the width of the potential.
In this report we have analyzed three different variants of
an scFv fragment with force spectroscopy using an atomic
force microscope (AFM). These variants represent a series of
clones obtained from different steps of an afﬁnity maturation
process by using ribosome display (11,22). All three variants
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bind the same peptide antigen, which is a random coil in
solution. The crystal structure of a closely related variant
complexed with the antigen has been determined (11). As
the peptide forms an a-helical structure in complex with the
antibody fragment, the peptide is considered to undergo a
conformational change upon binding and unbinding, giving
rise to more complex unbinding pathways compared to
the unbinding of small and compact ligands. The study de-
scribed here focuses on two aspects. First, we address some
methodological aspects of the AFM measurements, mainly
dealing with data evaluation. The obtained data were used to
compare two different methods for analyzing AFM mea-
surements. Both methods are based on the well-established
Bell-Evans model (23–25) and allow determination of the
koff and Dx values. In addition, the koff values obtained from
force spectroscopy measurements were compared with the
koff values determined by SPR. Second, as the variants only
differ in a few amino acids it is possible to examine the in-
ﬂuence of these mutations, acquired during the afﬁnity mat-
uration process, on koff and Dx.
MATERIALS AND METHODS
Cloning, expression, and puriﬁcation of the
antibody fragments
The three scFv variants (C11, C11L34, and 52SR4) were expressed with a
C-terminal His tag followed by a cysteine to allow site-speciﬁc immobiliza-
tion of the scFv fragments. The plasmids for periplasmic expression were
based on the pAK series (26). The gene for coexpression of the periplasmic
chaperone Skp was introduced (27). The original His tag was replaced by a
tag of six histidines followed by two glycines and a cysteine. For the ex-
pression and puriﬁcation of the scFv variants, the protocol of Hanes et al.
(22) was slightly modiﬁed. Brieﬂy, the Escherichia coli strain SB536 was
transformed with the plasmids. Cells were grown at 25C in SB medium
(20 g L1 tryptone, 10 g L1 yeast extract, 5 g L1 NaCl, 50 mM K2HPO4)
containing 30 mg ml1 chloramphenicol. Expression was induced with
1 mM isopropyl-b-D-thiogalactopyranoside at an OD600 between 1.0 and
1.5. The cells were harvested by centrifugation 3 h after induction. Cell
disruption was achieved by French Press lysis. The scFv fragments were
puriﬁed using two chromatography steps. After chromatography on a Ni21-
NTA column (Qiagen, Hilden, Germany) using standard protocols, the
eluted fraction was directly loaded onto an afﬁnity column with immobilized
antigen. The fractions from the afﬁnity column were dialyzed against
coupling buffer (50 mM sodium phosphate, pH 7.2, 50 mM NaCl, 10 mM
EDTA) and concentrated using Centricon YM-10 (Millipore, Eschborn,
Germany). The actual concentration of the puriﬁed scFv fragments was
determined by measuring the absorbance at 280 nm. The extinction coef-
ﬁcients of the different variants were calculated using the program Vector
NTI (Invitrogen, Karlsruhe, Germany). The preparations of the puriﬁed
proteins were adjusted to a concentration of 0.8 mg ml1 and stored in ali-
quots at 80C.
Preparation of slides and cantilevers for the
AFM measurements
Poly(ethylene) glycol (PEG) was used as a spacer between the biomolecules
and the surfaces. Due to its properties, PEG is an ideal spacer for force spec-
troscopy measurements (14,16,19,21,28–30). It provides protein-resistant
surfaces (31), thereby reducing the number of nonspeciﬁc binding events.
In addition, PEG shows a characteristic force-extension curve, allowing dis-
crimination between speciﬁc and nonspeciﬁc interactions during data anal-
ysis. The scFv fragments possessing a C-terminal Cys were immobilized
on an amino-functionalized slide using a heterobifunctional NHS-PEG-
maleimide (molecular mass 5000 g/mol; Nektar, Huntsville, AL). The
peptide GCN4(7P14P) (RMKQLEPKVEELLPKNYHLENEVARLKKL
VGER), which has been used for the generation and afﬁnity-maturation of
antibodies, was used for the force spectroscopy measurements (11,22,32). A
cysteine residue followed by three glycines was attached to the N-terminus
during peptide synthesis (Jerini Peptide Technologies, Berlin, Germany).
The Cys was used to couple the peptide to an amino-functionalized canti-
lever, again using the NHS-PEG-maleimide spacer (Fig. 1).
The cantilevers (Bio-lever, Olympus, Tokyo, Japan) were cleaned and
functionalized as described (21). However, instead of epoxy-functionalized
cantilevers, amino-modiﬁed surfaces were prepared using 3-aminopropyl-
dimethylethoxysilane (ABCR, Karlsruhe, Germany). Commercially available
amino-functionalized slides (Slide A, Nexterion, Mainz, Germany) were
FIGURE 1 Experimental setup. The antibody fragments having aC-terminal
cysteine were covalently immobilized onto amino-functionalized glass slides
using a heterobifunctional PEG spacer. The same coupling chemistry was used
for immobilizing the peptide on the cantilever.
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used. For the next steps, both surfaces (slide and cantilever) were treated
in parallel as described (33). Brieﬂy, they were incubated in borate buffer,
pH 8.5, to increase the fraction of unprotonated amino groups for coupling to
the NHS groups of the PEG. NHS-PEG-maleimide was dissolved at a con-
centration of 50 mM in borate buffer at pH 8.5 and incubated on the surfaces
for 1 h. In parallel, the peptide and one of the scFv fragments were reduced
using TCEP beads (Perbio Science, Bonn, Germany) to generate free thiols.
After washing both surfaces with ultrapure water, a solution of the peptide
(200 mM) was incubated on the cantilever and a solution of the scFv frag-
ment (0.13 mg/ml) was incubated on the slide for 1 h. Finally, both surfaces
were rinsed with phosphate-buffered saline (PBS) (10 mM Na phosphate,
pH 7.4, 137 mM NaCl, 2.7 mM KCl) to remove noncovalently bound
material and stored in PBS until use.
Force spectroscopy
All force measurements were performed with a MFP-1D AFM (Asylum
Research, Santa Barbara, CA) at room temperature in PBS. Cantilever spring
constants ranged from 6 to 8 pN/nm (B-Bio-Lever) and were measured as
described previously (34,35). During one experiment, the approach and re-
tract velocity were held constant, whereas the applied force was adjusted by
changing the distance between the cantilever tip and the surface to obtain single
binding events. To achieve good statistics, several hundreds of approach-
retract cycles were carried out. To obtain measurements over a broad range of
different loading rates, several experiments were performed, each at a dif-
ferent retract velocity ranging from 50 nm/s to 10 mm/s.
Data extraction
The obtained data was converted into force-extension curves. From these
force-extension curves, the rupture force (the force at which the antibody-
antigen complex ruptures), the rupture length, and the corresponding loading
rate were determined using the program Igor Pro 5.0 (Wavemetrics, Lake
Oswego, OR) and a custom-written set of procedures. The rupture force was
determined as described previously (24,25). The loading rate was deter-
mined using the two-state freely jointed chain ﬁt to the force-extension curve,
according to previous studies (36).
Data analysis
To analyze the data set obtained from one experiment, which was recorded at
a constant retract velocity, the rupture forces, rupture lengths, and loading
rates were plotted in three histograms. The loading rates were plotted log-
arithmically. The histograms were analyzed with two methods based on the
Bell-Evans model (23–25). The ﬁrst method refers to the basis of dynamic
force spectroscopy and has been applied broadly in the past to analyze force
spectroscopy data. The histograms of the force and the loading rate (plotted
logarithmically) for each data set, i.e., for each retract velocity, were ﬁtted
with a Gaussian distribution to determine the maxima. Finally, these
obtained maxima of the Gaussian distributions were plotted in a force versus
loading rate diagram. The maximum force (from the Gaussian distribution of
the force histogram) represents the most probable force F:
F
 ¼ kB3 T
Dx
ln
_F3Dx
kB3 T3 koff
; (1)
where kB is the Boltzmann constant, T the temperature, Dx the potential
width, koff the natural dissociation rate at zero force, and _F; equal to dF=dt; is
the loading rate. From a linear ﬁt of the force versus loading rate (pictured
logarithmically) plot and Eq. 1, koff and Dx of the antibody-antigen complex
can be determined.
Whereas the ﬁrst analysis method requires measurements at different
retract velocities, the values for koff and Dx can be obtained from one data set
measured at one retract velocity when using the second analysis method. The
second method was introduced by Friedsam et al. (25) and takes into account
a distribution of spacer lengths of the used PEG. The bond rupture prob-
ability density function p(F) was calculated according to Eq. 2 for every
spacer length in the measured rupture-length histogram:
pðFÞ ¼ koff 3 exp F3Dx
kB3 T
 
1
_F
3 exp koff
Z F
0
dF9exp
F93Dx
kB3 T
 
1
_F
 
: (2)
These p(F) functions were weighted according to their occurrence in the
rupture-length histogram and ﬁnally added up. This results in a semihypo-
thetical rupture-force histogram based on the two input parameters koff and
Dx, which were varied to ﬁnd the best ﬁt to the measured rupture-force
histogram. Additionally, to account for the detection noise, the probability
density function, p(F), was convolved with a Gaussian distribution. The
standard deviation of the Gaussian distribution equals the typical noise value
of the cantilever, which was used in the experiment (37).
The main difference between these two analysis methods is that the ﬁrst
method only uses the maxima of the force and loading-rate distributions for
the ﬁt procedure. As a consequence, the spacer length of the PEG spacer is
averaged, which therefore results in an averaged loading rate. In contrast, the
second method takes into account a certain spacer-length distribution. In
addition, with the second method, the force histogram is ﬁtted directly with
the probability density function and therefore considers the shape of the his-
togram. To analyze the experimentally obtained data using the second
method, it is extremely important to eliminate nonspeciﬁc interactions dur-
ing data analysis, as they can shift or broaden the force histogram. This would
lead to incorrect ﬁt values for koff and Dx.
Proof of speciﬁcity
To prove the speciﬁcity of the force spectroscopy measurements, experi-
ments were performed either without the antibody fragment or without the
peptide. By measuring the antibody fragment, attached to the surface, against a
cantilever tip passivated with PEG, .1000 force-extension curves were
recorded. Thereby, ,1% nonspeciﬁc interactions were detected. The mea-
surements without the peptide led to similar results.
SPR measurements
For the measurement of koff (25C) of the scFv fragments with a Biacore
3000 instrument (BIAcore, Freiburg, Germany), two different assay formats
were used: 1), an antigen-immobilized assay for clone C11; and 2), an
antibody-immobilized assay for the clones C11L34 and 52SR4. For both
formats, a CM5 sensor chip (BIAcore) was modiﬁed via amine coupling
according to the manufacturer’s protocol. For assay format 1, biotinylated
peptide GCN4(7P14P) (22) was bound to the amine-coupled neutravidin
(Perbio Science, Lausanne, Switzerland) surface to a ﬁnal signal intensity of
20 RU. Clone C11 was diluted in HBST buffer (20 mM Hepes, pH 7.2, 150
mM NaCl, 0.005% Tween 20) to ﬁnal concentrations of 20–100 nM and
injected on the chip. For format 2, either clone C11L34 or clone 52SR4 was
amine-coupled to the surface to a ﬁnal signal intensity of 100–300 RU. A
series of GCN4(7P14P) peptide solutions in HBST buffer in the range 50–
0.023 nM, using threefold dilutions, was injected on the chip. After binding,
dissociation was followed at a ﬂow rate of 100 ml/min and 50 ml/min for
assay formats 1 and 2, respectively. The dissociation phase was ﬁtted glob-
ally, using the single-exponential ﬁt function of the program SigmaPlot or
Clamp, alternatively.
RESULTS
The antibody fragments used in our study are closely related
and have been described previously (11,22). They all bind
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the same peptide antigen, which has been derived from the
transcription factor GCN4. For a better understanding, we
brieﬂy summarize the positions (Table 1) and the inﬂuence
of the mutations. The antibody fragments differ in a few
amino acids only. Starting from clone C11, clone C11L34
has one mutation. Compared to clone C11L34, clone 52SR4
has four additional mutations. The mutated amino acids do
not interact directly with the antigen, although three of them
are located in the complementarity determining regions
(CDRs). Mutation L42 (N/S; AHo numbering scheme
(38)), which has already been introduced into clone C11L34,
may reduce the ﬂexibility of CDR L1 and may allow a more
favorable domain orientation. Mutation L107 (A/V) of
clone 52SR4 lies in close proximity to mutation L42 and
therefore might contribute to this effect. Therefore, these two
mutations are thought to inﬂuence the loop position and/or
geometry and the relative domain orientation and thereby
optimize the binding geometry. Most likely, mutation L135
(N/D in clone 52SR4) has a different effect. The exchange
of asparagine to aspartic acid introduces a negative charge.
This charged residue might be able to establish an electro-
static interaction with the peptide, as the peptide has a pos-
itive charge at the corresponding position (K15 in the original
peptide). From the structure, it appears that the mutations L13
(T/S in clone 52SR4) and H30 (S/L in clone 52SR4)
only have a small contribution to the afﬁnity.
To analyze the interaction of the variants with their pep-
tide antigen, force spectroscopy measurements were per-
formed using an atomic force microscope (AFM). To be able
to compare the two different analysis methods for the AFM
data (see Materials and Methods) and the data from the sur-
face plasmon resonance (SPR) measurements, it was essen-
tial to minimize nonspeciﬁc interactions and to ensure that
only speciﬁc and single antibody-peptide interactions were
analyzed. As an effective approach to discriminate nonspe-
ciﬁc interactions, we chose to attach both the antibody frag-
ment and the peptide via PEG, which is known to provide
protein-resistant surfaces. The antibody fragment was cou-
pled to a surface containing covalently attached PEG and the
peptide was immobilized onto the cantilever tip in the same
way (Fig. 1). An additional advantage of this approach is that
PEG acts as an elastic spacer with a known length. When the
PEG spacers are stretched, the elastic properties of this mol-
ecule lead to a characteristic extension curve, which can be
ﬁtted with the two-state freely jointed chain (FJC) ﬁt with the
values from the literature (36). Speciﬁc interactions were
thus selected by considering only those extension curves that
show the appropriate length and the characteristic shape of
the PEG spacers.
In all experiments, the surface was approached with the tip
of the cantilever, allowing the antibody-peptide complex
to bind. Subsequently, the cantilever was retracted and the
antibody-peptide complex was loaded with an increasing
force until the complex ﬁnally ruptured and the cantilever
relaxed back into its equilibrium position. The force applied
to this complex was recorded as a function of the distance be-
tween the cantilever tip and the surface. Fig. 2 shows a series
of typical force-extension curves representing the interaction
between clone C11 and the peptide. To obtain good statistics,
several hundred force-extension curves were recorded for
all three variants. From these curves, the rupture force, rup-
ture length, and corresponding loading rate were determined.
Fig. 3 a shows the rupture-force, Fig. 3 b the rupture-length,
and Fig. 3 c the loading-rate distributions for the interaction
of clone C11 with the peptide, measured at a retract velocity
of 1000 nm/s. The rupture-force histogram in Fig. 3 a was
ﬁtted with a Gaussian distribution (dotted curve) and exhibits
a most probable force of 55.6 pN. The Gaussian distribution
of the histogram of the loading rates (plotted logarithmically)
(Fig. 3 c) shows a maximum at 2697 pN s1. The maxima of
the force and the loading-rate distributions were determined
for a large range of loading rates, and in the following step
were plotted in a force versus loading rate (pictured logarith-
mically) diagram (ﬁrst analysis method). The determination
of koff and Dx from a linear ﬁt to these data points using Eq. 1
is described in Materials and Methods. The measurements of
clone C11 resulted in a koff of (3.9 6 5.7) 3 10
3 s1 and a
Dx of (0.88 6 0.12) nm. For a complete analysis of the
experimental results, all data sets for the three variants were
examined by the ﬁrst analysis method, using Eq. 1 (Fig. 4).
The obtained values for koff and Dx for all three variants are
listed in Table 1.
Additionally, the measured rupture-force distributions for
all three variants were analyzed using the second analysis
TABLE 1 Summary of the results obtained for the three different clones
AFM analysis method 1 AFM analysis method 2* SPR
Clone Mutations koff (s
1) Dx (nm) koff (s
1) Dx (nm) koff (s
1)
C11 None (3.9 6 5.7) 3 103 0.88 6 0.12 (1.0 6 0.3) 3 103 0.90 6 0.02 2.9 3 103
C11L34 L42 (N/S) (4.9 6 7.2) 3 104 0.90 6 0.10 (2.0 6 1.0) 3 104 1.00 6 0.10 3.0 3 104
52SR4 L13 (T/S) (8.2 6 7.9) 3 104 0.92 6 0.07 (5.0 6 2.0) 3 104 0.86 6 0.04 1.6 3 104
L42 (N/S)
L107 (A/V)
L135 (N/D)
H30 (S/L)
*koff and Dx for the analysis method 2 have been determined for dF/dt between 80 and 90 pN s
1.
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method based on the probability density function p(F) (Eq. 2).
The respective ﬁt for the presented data set of clone C11 is
shown in Fig. 3 (solid curve). For this clone, the second
analysis method resulted in a Dx of (0.96 0.03) nm and a koff
of (2.0 6 3.0) 3 103 s1. To be able to compare the ob-
tained values for koff and Dx for all the variants, we performed
an analysis for similar loading rates in the lower range (dF/dt
between 80 and 90 pN s1). The values for all three variants
are also listed in Table 1. A comparison of the three different
variants shows that the Dx and koff values, determined using
the ﬁrst and second analysis methods, are identical within the
analysis error (ﬁrst analysis method). The values for koff
obtained from the SPR measurements are also summarized
in Table 1. Within experimental error, both methods (AFM
and SPR) exhibit consistent values for koff for all three
variants.
A statistical analysis of the results obtained from the ﬁrst
analysis method using the AFM was performed using Stu-
dent’s t-tests. The potential widths Dx of the three variants
have been determined from the corresponding slopes of the
linear ﬁts (see Materials and Methods), which are identical
with a probability of 96%. Thus, none of the mutations
changes the potential width, Dx, signiﬁcantly. In contrast, the
dissociation rates, koff, were determined from the interpolation
to zero force. Since the slopes are identical, the significance
in the difference in koff can be obtained from the intersections
of the linear ﬁts with the ordinate.
These intersections for clones C11 and C11L34 are dif-
ferent with a probability of 66%. This rather low value
results from the lack of data points at very low loading rates
that are not accessible with the AFM. Since the AFM data
from the ﬁrst and second analysis methods are in full accor-
dance with the SPR results, a comparison of the koff values
clearly reveals that clone C11L34 has a slower dissociation
rate than clone C11 (5–8-fold). This is the consequence of
one single-point mutation at the end of CDR L1 of the VL
domain. Clones C11L34 and 52SR4 differ in four amino
acids. However, these mutations do not show any signiﬁcant
inﬂuence on koff.
FIGURE 2 Example of seven typical force-extension curves. The force-
extension curves show the rupture event of the scFv C11 peptide complex,
experimentally recorded at a retract velocity of 1000 nm/s. The elastic
behavior of the spacer PEG can be described using the two-state FJC ﬁt
(solid curve) with the values from the literature (36). The values for the
rupture force, rupture length, and corresponding loading rate were obtained
from these force-extension curves.
FIGURE 3 Example of the obtained rupture-force, rupture-length, and
loading-rate distributions. (a) Rupture-force histogram of the scFv C11 peptide
complex. The rupture-force histogram contains 859 rupture events and was
ﬁtted with a Gaussian curve (dotted curve). Additionally, the obtained rupture-
force distribution was compared with the calculated probability density
function p(F) (solid curve) with Dx ¼ (0.96 0.03) nm and koff ¼ (2.06 3.0)
3 103 s1, as described in Materials and Methods. Within the analysis error,
the values for Dx and koff are identical for both analysis methods (experimental
data obtained from the ﬁrst analysis method are shown in Fig. 4). (b) Rupture-
length histogram of the scFv C11 peptide complex. (c) Histogram of the
loading rates of the scFv C11 peptide complex, plotted logarithmically. This
histogram was ﬁtted with a Gaussian curve (dotted curve) and additionally
compared with the calculated probability density function pðln _FÞ (solid curve).
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DISCUSSION
Receptor-ligand interactions often display a marked devia-
tion from the linear relation between the unbinding force and
the logarithm of the force-loading rate, predicted by the Bell-
Evans model. Biotin-Avidin (39) and digoxigenin-antibody
interactions (21) are prominent examples, where two barriers
in series are suggested due to the marked nonlinearity. Alter-
natively, other models based on the Kramers theory (40,41)
are discussed. For the antibody-peptide system investigated
here, we found that the simplest level of analysis, which is
based on a mechanothermally activated transition in a two-
level system, already provided a satisfactory description of
the unbinding process: for each mutant, the plot in Fig. 4
revealed a linear relation, showing virtually indistinguish-
able slopes and a separation of the intersections at zero force.
However, this simple approach has two severe drawbacks:
it requires the measurement of a series of data points for a
wide spectrum of force-loading rates and it assumes a mono-
disperse spacer length. This has only a limited validity if poly-
meric spacers, such as PEG, are used (as in this study). We
therefore also employed a second method, which analyzes
the shape of the rupture-force histogram and requires only
one loading rate. We found that this method provided more
accurate results (see Table 1), as it considers the distribution
of the spacer lengths (25). For all three variants used in this
study, the koff and Dx values agreed well for both analysis
methods for slow loading rates. In general, the second anal-
ysis method may also be applied to faster loading rates (data
not shown). However, for faster loading rates, the experi-
mental noise increases and, therefore, additional correction
factors would have to be included for analysis of the data
(37). In addition, one should keep in mind that the Bell-
Evans model assumes a constant Dx over the entire range
of loading rates, which is probably not the case for most
receptor-ligand systems. Therefore, using the second analysis
method for slow loading rates ensures that the potential width
is not changed, as the system is still close to equilibrium.
Last but not least, this second method also reduces the
experimental effort signiﬁcantly, as the potential width and
the dissociation rate are obtained from one experiment at one
loading rate only, thereby making the method competitive
with SPR measurements. This is particularly true in view of
the rebinding problems that may hamper SPR analysis for
very low koff values. A decreasing koff results in an increasing
binding force, thus making this regime favorable for single-
molecule force spectroscopy. The main advantage, however,
lies in the accessibility of an otherwise not measurable param-
eter of receptor-ligand interactions: their potential width, Dx.
The most remarkable ﬁnding of our study is that the dif-
ferent variants have a more or less identical potential width,
which is calculated from the indistinguishable slopes of the
linear ﬁts of the different clones. Although, in the Bell-Evans
model, the potential width is only a rough measure of the
steepness of the binding potential or, in other words, a mea-
sure of how far the binding complex can be stretched and
deformed until it ﬁnally ruptures, this ﬁnding leads to the
conclusion that neither the geometry of the binding site nor
the unbinding pathways were signiﬁcantly affected by the
mutations introduced during the afﬁnity-maturation process.
Compared to the potential width of the well characterized
antiﬂuorescein scFv fragments (14,42,43), the value for Dx
obtained for the system analyzed here is signiﬁcantly higher.
In addition, for the ﬂuorescein system a correlation between
Dx and koff was observed, which is not the case for the variants
investigated here. When comparing both systems, one has to
keep in mind that there are three signiﬁcant differences. First,
in the ﬂuorescein system the mutations are mainly located in
the binding sites of the scFv fragments. Second, in the ﬂuo-
rescein system, afﬁnity-matured scFv fragments were taken as
a starting point and systematic mutations were made to reduce
the number of contacts in the binding site. In the study pre-
sented here, a starting clone was improved sequentially by
directed evolution. And ﬁnally, ﬂuorescein is a very rigid
antigen, which cannot adopt multiple conformations. In con-
trast, the peptide antigen of the system described here is a
random coil in solution and has an a-helical structure in
complex with the antibody fragment.
Considering these aspects, the observed differences for Dx
can be rationalized as follows: during the forced unbinding,
one or both binding partners can be deformed in the direction
of the applied force. If a certain point is reached, the defor-
mation is so large that the complex dissociates. In the case
of the antiﬂuorescein scFvs, the number and quality of the
FIGURE 4 Diagram showing the most probable rupture force plotted
against the corresponding loading rate (pictured logarithmically) for all three
scFv-peptide complexes. The data points were gained from the Gaussian ﬁts
of the rupture-force histogram and the histogram of loading rates, plotted
logarithmically. The black data points (n) correspond to the scFv C11
peptide complex. These data points were ﬁtted to a straight line (black dotted
curve). From this linear ﬁt, Dx ¼ (0.886 0.12) nm and koff¼ (3.96 5.7)3
103 s1 were obtained. The dark gray data set (d) was measured for the
forced dissociation of the scFv C11L34 peptide complex. From the linear
ﬁt (dark gray), Dx ¼ (0.90 6 0.10) nm and koff ¼ (4.9 6 7.2) 3 104 s1
were obtained. Finally, the scFv 52SR4 peptide complex, plotted with light
gray data points (:) and the linear ﬁt (light gray dashed curve) gave Dx ¼
(0.92 6 0.07) nm and koff ¼ (8.2 6 7.9) 3 104 s1.
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contacts in the binding site differs among the analyzed scFvs.
As ﬂuorescein is a rigid antigen, only the scFv fragment itself
can respond to the applied force. Therefore, by stretching the
scFv fragment with an externally applied force, it is de-
formed in the direction of the force. Finally, the contacts in
the binding site cannot resist the force any longer, and the
complex ruptures. Therefore, the correlation between Dx and
koff can be explained by the fact that a complex with a higher
koff is stabilized by a lower number of contacts and can with-
stand smaller deformations until the complex dissociates.
However, for the system investigated here, the antigen is
extremely ﬂexible. The helical peptide ismost likely stretched
along its axis, so that a deformation can be induced easily by
applying force. In addition, a deformation of the scFv, as
observed for the antiﬂuorescein scFvs (42), might occur. That
the values for Dx are identical leads to the conclusion that the
unbinding process is the same for all variants: before the
antibody-peptide complex ﬁnally dissociates, the peptide has
to be stretched far enough to destabilize the complex. This
point of destabilization is identical for the variants. As no
additional contacts have been introduced in the binding site
during the afﬁnity-maturation process, a stabilization of the
complex is only conceivable if the binding site is more rigid
and possesses a higher resistance to the applied force. This can
be realized with a lower koff value. Indeed, the only relevant
mutation that improves koff among themutants examined here
is the mutation in clone C11L34, which is assumed to reduce
the ﬂexibility of CDR L1. This interpretation can also be
supported by the fact that the ﬂexibility of the binding pocket
can be reduced during the afﬁnity maturation process in vivo,
as found in other antibody systems (44–46).
This latter ﬁnding is an interesting aspect of the afﬁnity
maturation process. However, more data from more, different
variants would be needed to investigate whether evolution
to higher afﬁnity generally results in more rigid binding sites.
Furthermore, it would be of great interest to investigate the
forced unbinding process of the antibody-peptide system in
much greater detail. As the structure of the complex is known,
molecular dynamics simulations in combination with addi-
tional experiments can provide further insights (42,43,47). For
example, it would be interesting to measure whether truncated
or mutated peptides show an altered potential width. In
addition, the system investigated here is an interesting model
system to investigate whether the unbinding pathway is inﬂu-
enced by the direction of the applied force. This can be easily
tested by changing the site of attachment of the peptide.Amore
detailed understanding of the response of biological systems
to externally applied forces is of great importance. Even ther-
modynamically very stable complexes can rupture at low
forces, and, conversely, complexes with identical dissociation
rates can withstand a broad range of forces depending on
the potential width. As more and more systems are discovered
that respond to forces in their natural environment, a more
detailed knowledge is required of the mechanisms governing
how molecules sense and detect forces in biological systems.
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